Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Angelin

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Cell Metabolism|October 11, 2005
Telling the liver (not) to make bile acids: a new voice from the gut?Bo Angelin
Trends in Molecular Medicine|January 14, 2017
Metabolic Syndrome: One Speckled Stone Kills a Flock of Birds?Ylva Bonde, Bo Angelin
Current Opinion in Lipidology|October 12, 2010
Lipid lowering with thyroid hormone and thyromimeticsBo Angelin, Mats Rudling
Atherosclerosis. Supplements|February 8, 2003
Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDLBo Angelin, Paolo Parini, Mats Eriksson
Endocrinology|April 17, 2002
Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterolCecilia Gälman, Bo Angelin, Mats Rudling
American Journal of Physiology. Endocrinology and Metabolism|March 18, 2004
Pituitary control of lipoprotein and bile acid metabolism in male rats: growth hormone effects are not mediated by prolactinManuela Matasconi, Bo Angelin, Mats Rudling
Current Opinion in Lipidology|June 28, 2013
Interstitial fluid lipoproteinsJohanna Lundberg, Mats Rudling, Bo Angelin
Gastroenterology|November 16, 2005
Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesisCecilia Gälman, Bo Angelin, Mats Rudling
Cell Metabolism|December 11, 2012
Circulating fibroblast growth factors as metabolic regulators--a critical appraisalBo Angelin, Tobias E Larsson, Mats Rudling
Gastroenterology|June 22, 2018
An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy VolunteersAmani Al-Khaifi, Mats Rudling, Bo Angelin
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Cell Metabolism|October 11, 2005
Telling the liver (not) to make bile acids: a new voice from the gut?Bo Angelin
Trends in Molecular Medicine|January 14, 2017
Metabolic Syndrome: One Speckled Stone Kills a Flock of Birds?Ylva Bonde, Bo Angelin
Current Opinion in Lipidology|October 12, 2010
Lipid lowering with thyroid hormone and thyromimeticsBo Angelin, Mats Rudling
Atherosclerosis. Supplements|February 8, 2003
Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDLBo Angelin, Paolo Parini, Mats Eriksson
Endocrinology|April 17, 2002
Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterolCecilia Gälman, Bo Angelin, Mats Rudling
American Journal of Physiology. Endocrinology and Metabolism|March 18, 2004
Pituitary control of lipoprotein and bile acid metabolism in male rats: growth hormone effects are not mediated by prolactinManuela Matasconi, Bo Angelin, Mats Rudling
Current Opinion in Lipidology|June 28, 2013
Interstitial fluid lipoproteinsJohanna Lundberg, Mats Rudling, Bo Angelin
Gastroenterology|November 16, 2005
Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesisCecilia Gälman, Bo Angelin, Mats Rudling
Cell Metabolism|December 11, 2012
Circulating fibroblast growth factors as metabolic regulators--a critical appraisalBo Angelin, Tobias E Larsson, Mats Rudling
Gastroenterology|June 22, 2018
An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy VolunteersAmani Al-Khaifi, Mats Rudling, Bo Angelin
Pageof 7